Endovascular vs medical management of acute ischemic stroke

Neurology

Volumn 85, Issue 22, 2015, Pages 1980-1990

  Chen, Ching Jen ^a   Ding, Dale ^a   Starke, Robert M ^a   Mehndiratta, Prachi ^a   Crowley, R Webster ^a   Liu, Kenneth C ^a   Southerland, Andrew M ^a   Worrall, Bradford B ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR; FIBRINOLYTIC AGENT;

ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBRAL REVASCULARIZATION; COMPARATIVE EFFECTIVENESS; HUMAN; MECHANICAL THROMBECTOMY; META ANALYSIS; MORTALITY; MULTICENTER STUDY (TOPIC); PATIENT SAFETY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RANKIN SCALE; STENT RETRIEVER; STROKE PATIENT; SYSTEMATIC REVIEW; TREATMENT OUTCOME; DISEASE MANAGEMENT; ENDOVASCULAR SURGERY; FIBRINOLYTIC THERAPY; PROCEDURES; STROKE; THROMBECTOMY;

BRAIN ISCHEMIA; DISEASE MANAGEMENT; ENDOVASCULAR PROCEDURES; FIBRINOLYTIC AGENTS; HUMANS; STROKE; THROMBECTOMY; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84948958432     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000002176     Document Type: Article

References (27)

1. Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics: 2015 update: a report from the American Heart Association. Circulation 2015; 131: e29-322
2. Smith WS, Lev MH, English JD, et al. Significance of large vessel intracranial occlusion causing acute ischemic stroke and TIA. Stroke 2009; 40: 3834-3840
3. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-1587
4. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008; 359: 1317-1329
5. Bhatia R, Hill MD, Shobha N, et al. Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action. Stroke 2010; 41: 2254-2258
6. Broderick JP, Palesch YY, Demchuk AM, et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 2013; 368: 893-903
7. Kidwell CS, Jahan R, Gornbein J, et al. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med 2013; 368: 914-923
8. Ciccone A, Valvassori L, Nichelatti M, et al. Endovascular treatment for acute ischemic stroke. N Engl J Med 2013; 368: 904-913
9. Przybylowski CJ, Ding D, Starke RM, Durst CR, Crowley RW, Liu KC. Evolution of endovascular mechanical thrombectomy for acute ischemic stroke. World J Clin Cases 2014; 2: 614-622
10. Berkhemer OA, Fransen PS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2015; 372: 11-20
11. Campbell BC, Mitchell PJ, Kleinig TJ, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 2015; 372: 1009-1018
12. Goyal M, Demchuk AM, Menon BK, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 2015; 372: 1019-1030
13. Jovin TG, Chamorro A, Cobo E, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med 2015; 372: 2296-2306
14. Saver JL, Goyal M, Bonafe A, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med 2015; 372: 2285-2295
15. Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy: ASPECTS Study Group: Alberta Stroke Programme Early CT Score. Lancet 2000; 355: 1670-1674
16. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [online]. Available at: http://www.cochrane-handbook.org. Accessed May 2, 2015
17. Alexandrov AV, Molina CA, Grotta JC, et al. Ultrasoundenhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 2004; 351: 2170-2178
18. del Zoppo GJ, Poeck K, Pessin MS, et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 1992; 32: 78-86
19. Ribo M, Alvarez-Sabin J, Montaner J, et al. Temporal profile of recanalization after intravenous tissue plasminogen activator: selecting patients for rescue reperfusion techniques. Stroke 2006; 37: 1000-1004
20. Mocco J, Fiorella D, Fargen KM, et al. Endovascular therapy for acute ischemic stroke is indicated and evidence based: a position statement. J Neurointerv Surg 2015; 7: 79-81
21. Khalessi AA, Fargen KM, Lavine S, Mocco J. Commentary: Societal statement on recent acute stroke intervention trials: results and implications. Neurosurgery 2013; 73: E375-E379
22. Demchuk AM, Goyal M, Yeatts SD, et al. Recanalization and clinical outcome of occlusion sites at baseline CT angiography in the Interventional Management of Stroke III TRIAL. Radiology 2014; 273: 202-210
23. Broderick JP, Palesch YY, Demchuk AM, et al. Evolution of practice during the Interventional Management of Stroke III Trial and implications for ongoing trials. Stroke 2014; 45: 3606-3611
24. Nogueira RG, Lutsep HL, Gupta R, et al. Trevo versusMerci Retrievers for Thrombectomy Revascularisation of Large Vessel Occlusions in Acute Ischaemic Stroke (TREVO 2): a randomised trial. Lancet 2012; 380: 1231-1240
25. Saver JL, Jahan R, Levy EI, et al. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet 2012; 380: 1241-1249
26. van den Berg LA, Koelman DL, Berkhemer OA, et al. Type of anesthesia and differences in clinical outcome after intra-arterial treatment for ischemic stroke. Stroke 2015; 46: 1257-1262
27. Schonenberger S, Mohlenbruch M, Pfaff J, et al. Sedation vs. intubation for endovascular stroke treatment (SIESTA): a randomized monocentric trial. Int J Stroke Epub 2015 Apr 12